In context
Palmitoyl hexapeptide-12 was studied using non-invasive techniques to examine its interaction with human skin layers and skin mechanics. [1]
At a glance
- Type
- Topical cosmetic ingredient
- Regulatory context
- The cited source describes research, not a determination of present marketing authorisation. Country, formulation and indication must be checked separately.
- Evidence
- Short-term physical measurements are different from durable clinical improvement. A topical ingredient study cannot support systemic use.
How to interpret this evidence
Short-term physical measurements are different from durable clinical improvement. A topical ingredient study cannot support systemic use. [1]
Safety and clinical context
Topical cosmetic research does not support injection or other systemic use. Safety and tolerability depend on the complete formulation and the person using it.
Evidence and authorisation depend on the product, formulation, indication and country. US labelling does not establish Thai authorisation. This guide is educational and is not a dosing or self-treatment protocol.
Primary sources
Read the underlying source and its limitations. A study citation does not by itself establish efficacy or approval.